Aspirin-induced asthma: a still evolving area of basic and clinical research.
Sanak M.
Pol Arch Intern Med. 2022 Feb 28;132(2):16219. doi: 10.20452/pamw.16219. Epub 2022 Feb 28.
Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes.
Gans MD, Gavrilova T.
Paediatr Respir Rev. 2020 Nov;36:118-127. doi: 10.1016/j.prrv.2019.08.002. Epub 2019 Oct 9.
The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
Stevens WW, Jerschow E, Baptist AP, Borish L, Bosso JV, Buchheit KM, Cahill KN, Campo P, Cho SH, Keswani A, Levy JM, Nanda A, Laidlaw TM, White AA.
J Allergy Clin Immunol. 2021 Mar;147(3):827-844. doi: 10.1016/j.jaci.2020.10.043. Epub 2020 Dec 9.
Recent Updates in Understanding NSAID Hypersensitivity.
Minaldi E, Cahill K.
Curr Allergy Asthma Rep. 2023 Mar;23(3):181-188. doi: 10.1007/s11882-023-01064-3. Epub 2023 Feb 9.
Aspirin-induced asthma: pathogenesis and clinical presentation.
Szczeklik A.
Allergy Proc. 1992 Jul-Aug;13(4):163-73. doi: 10.2500/108854192778817211.
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.
Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, Bonini M, Heffler E, Klimek L, Laidlaw TM, Mullol J, Niżankowska-Mogilnicka E, Park HS, Sanak M, Sanchez-Borges M, Sanchez-Garcia S, Scadding G, Taniguchi M, Torres MJ, White AA, Wardzyńska A.
Allergy. 2019 Jan;74(1):28-39. doi: 10.1111/all.13599. Epub 2018 Oct 2.
Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M, Sanak M, Bochenek G, Stręk P, Ćmiel A, Gielicz A, Plutecka H, Szczeklik A, Niżankowska-Mogilnicka E.
J Allergy Clin Immunol. 2014 Oct;134(4):883-90. doi: 10.1016/j.jaci.2014.02.041. Epub 2014 Apr 24.
Perimenstrual Asthma in Aspirin-Exacerbated Respiratory Disease.
Eid RC, Palumbo ML, Cahill KN.
J Allergy Clin Immunol Pract. 2020 Feb;8(2):573-578.e4. doi: 10.1016/j.jaip.2019.08.054. Epub 2019 Sep 30.
New insights on the possible role of mast cells in aspirin-induced asthma.
Mortaz E, Engels F, Nijkamp FP, Redegeld FA.
Curr Mol Pharmacol. 2009 Jun;2(2):182-9. doi: 10.2174/1874467210902020182.
Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
Buchheit KM, Lewis E, Gakpo D, Hacker J, Sohail A, Taliaferro F, Berreondo Giron E, Asare C, Vukovic M, Bensko JC, Dwyer DF, Shalek AK, Ordovas-Montanes J, Laidlaw TM.
J Allergy Clin Immunol. 2021 Aug;148(2):574-584. doi: 10.1016/j.jaci.2021.05.043. Epub 2021 Jun 16.
